Home »
Cancer is the second leading cause of death globally, accounting for nearly 10 million deaths each year. Late-stage diagnosis is a major contributor of cancer-related mortality, as...
With the August 2020 U.S. Food and Drug Administration approvals of the Guardant 360 CDx and FoundationOne Liquid CDx...
Early detection of most cancers is an elusive and daunting task; nevertheless, it has remained a top priority for...
This year, the AACR Annual Meeting, the premier cancer research meeting in the world, is happening at the Georgia...
Biopsies have been an integral part of cancer care for decades. In undiagnosed patients, oncologists can examine suspicious tissues...
Television series like CSI: Crime Scene Investigation familiarized viewers with advances in forensic science that allow investigators to detect...
Early detection of cancer is arguably a holy grail in the field of cancer research. Catching the disease at...
On June 1, the U.S. Food and Drug Administration (FDA) approved a liquid biopsy test, a companion diagnostic test...
AACR is the proud Scientific Partner for Stand Up To Cancer (SU2C), and for Colorectal Cancer Awareness Month, we...
Guest Post by Wafik S. El-Deiry, MD, PhD, FACP Fox Chase Cancer Center